Caribou Biosciences CRBU
NASDAQ CRBU
$0.39 -0.02 (-4.80%)
At close: Nov 11, 2026 · 4:00 PM EST

Caribou Biosciences (CRBU) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Caribou Biosciences (CRBU) posted Return on Capital Employed [ROCE] of -85.58% for Q2 2026, down 8.84 percentage points from -76.74% a year earlier but up 6.84 percentage points from the prior quarter.

Analysis

Caribou Biosciences (CRBU) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Caribou Biosciences' Return on Capital Employed [ROCE] came in at -67.76%, down 19.06 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for three consecutive years, with a four-year change of -36.37 percentage points (FY2021 to FY2025).
  • In prior years, Caribou Biosciences' Return on Capital Employed [ROCE] was -48.70% in FY2024 (-17.73 pp), -30.98% in FY2023 (-2.97 pp), -28.00% in FY2022 (+3.39 pp) and -31.39% in FY2021.
  • Quarterly Return on Capital Employed [ROCE] has run from a low of -92.85% in Q4 2025 to a high of -15.99% in Q4 2021 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last nine quarters, with an average year-over-year change of -28.68 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q4 2023, with a gain of 1.85 percentage points; the weakest was Q3 2025, with a drop of 37.66 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -92.42% (Q1 2026), -92.85% (Q4 2025) and -88.26% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Caribou Biosciences 44.30 Mn -419.78 Mn - -95.53%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -95.53%
Jun 30, 2026 -85.58%
Mar 31, 2026 -92.42%
Dec 31, 2025 -92.85%
Sep 30, 2025 -88.26%
Jun 30, 2025 -76.74%
Mar 31, 2025 -61.71%
Dec 31, 2024 -55.88%
Sep 30, 2024 -50.60%
Jun 30, 2024 -39.44%
Mar 31, 2024 -33.53%
Dec 31, 2023 -27.86%
Sep 30, 2023 -28.81%
Jun 30, 2023 -38.54%
Mar 31, 2023 -34.98%
Dec 31, 2022 -29.71%
Sep 30, 2022 -25.24%
Jun 30, 2022 -21.81%
Mar 31, 2022 -18.16%
Dec 31, 2021 -15.99%
API Access

Caribou Biosciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CRBU&period=max&api_key=YOUR_API_KEY